Clovis Oncology to Present at the Goldman Sachs 39th Annual Global Healthcare Conference 2018
Jun. 11, 2018
BOULDER, Colo.--(BUSINESS WIRE)--Jun 11, 2018--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the Goldman Sachs 39 th Annual Global Healthcare Conference on Tuesday, June 12, 2018 at 4:00 PM Pacific Time. The conference will be held at the Terranea Resort in Rancho Palos Verdes, CA.
A live webcast of the presentation can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK. Please visit www.clovisoncology.com for more information.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180611005953/en/
CONTACT: Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
Breanna Burkart, 303-625-5023
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA COLORADO
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS ONCOLOGY PHARMACEUTICAL MEDICAL SUPPLIES
SOURCE: Clovis Oncology, Inc.
Copyright Business Wire 2018.
PUB: 06/11/2018 04:05 PM/DISC: 06/11/2018 04:05 PM